Quantcast

Posts related to ‘OMRI’

Jnj_logo_2

Omrix Gets Acquired By J&J (OMRI, JNJ)

It looks as though not quite all the mergers are dead on the medical tech and biotechnology front.  Johnson & Johnson (NYSE: JNJ) announced that it is acquiring Omrix Biopharmaceuticals, ...
Read Full Story »

Top Pre-Market Analyst Upgrades (AER, AGU, CF, GVA, MFLX, OMRI, PM, PFG, TRA)

These are some the top pre-market upgrades from analysts we have seen with more than two hours until the market opens this Tuesday morning:AerCap (AER) Raised to Buy at Citigroup.Agrium ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading:Bristol-Myers (NYSE: BMY) cut to Neutral at Cowen.Marriott (NYSE: MAR) cut to Perform at ...
Read Full Story »

Biotech Busine$$ Daily (CRXX, CORT, OMRI, SIRT)

CombinatoRx, Incorporated (NASDAQ: CRXX) up 8% to $3.45 on no recent developments. The 52-week range is $3.11 to $7.37. Yesterday, the company hit a 52-week low so perhaps it had ...
Read Full Story »

The 52-Week Low Club (MS)(LEH)(WB)(FNM))(MER)(C)(JPM)

Thornburg Mortgage (NYSE: TMA) Fear of Chapter 11. Falls to $1.26 from 52-wek high of $28.40.CIT Group (NYSE: CIT) Lehman Brothers cuts price target. Drops to $15 from 52-week high ...
Read Full Story »

Biotech News Day (February 4, 2008) (AMAG, AOB, AMGN, CELG, MNTA, OMRI, SVA, STEM)

Below are some of the top issues affecting biotech shares today:AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4% to $56.00 ...
Read Full Story »